BIOMAT Database Logo BIOMAT Database Logo

Decahydroquinoline alkaloids: noncompetitive blockers for nicotinic acetylcholine receptor-channels in pheochromocytoma cells and Torpedo electroplax. 1991

J W Daly, and Y Nishizawa, and W L Padgett, and T Tokuyama, and P J McCloskey, and L Waykole, and A G Schultz, and R S Aronstam
Laboratory of Bioorganic Chemistry, National Institutes of Health, Bethesda, Maryland 20892.

In pheochromocytoma PC12 cells, (+)-cis-decahydroquinoline 195A (5-methyl-2-propyl-cis-decahydroquinoline) and (+)-perhydro-cis-decahydroquinoline 219A (2,5-dipropyl-cis-decahydroquinoline) inhibit carbamylcholine-elicited sodium flux with IC50 values of 1.0 and 1.5 microM, respectively. Both of these decahydroquinolines appear to enhance desensitization, although apparent lack of complete removal of (+)-perhydro-cis-219A by washing complicates interpretation of the effects of that agent. A series of cis- and trans-decahydroquinolines with substituents in the 2- and 5-position also exhibit structure-dependent inhibition of carbamylcholine-elicited sodium flux in PC12 cells and all of the decahydroquinolines inhibit binding of the noncompetitive blocking agent [3H]perhydrohistrionicotoxin to muscle-type nicotinic acetylcholine receptor-channels in membranes from Torpedo electroplax. The Ki values in electroplax membranes range from 1.4 to 7.9 microM, making these alkaloids comparable in potencies to the histrionicotoxins. Potencies are increased 2- to 3-fold in the presence of an agonist, carbamylcholine. The profile of activities are similar in PC12 cells and electroplax membranes. The cis- and trans-decahydroquinolines represent another class of noncompetitive blockers for acetylcholine receptor-channels with similar activity for both muscle-type and ganglionic type nicotinic receptors.

UI MeSH Term Description Entries
D011804 Quinolines
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D004557 Electric Organ In about 250 species of electric fishes, modified muscle fibers forming disklike multinucleate plates arranged in stacks like batteries in series and embedded in a gelatinous matrix. A large torpedo ray may have half a million plates. Muscles in different parts of the body may be modified, i.e., the trunk and tail in the electric eel, the hyobranchial apparatus in the electric ray, and extrinsic eye muscles in the stargazers. Powerful electric organs emit pulses in brief bursts several times a second. They serve to stun prey and ward off predators. A large torpedo ray can produce of shock of more than 200 volts, capable of stunning a human. (Storer et al., General Zoology, 6th ed, p672) Electric Organs,Organ, Electric,Organs, Electric
D000470 Alkaloids Organic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. (Grant & Hackh's Chemical Dictionary, 5th ed) Alkaloid,Plant Alkaloid,Plant Alkaloids,Alkaloid, Plant,Alkaloids, Plant
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014101 Torpedo A genus of the Torpedinidae family consisting of several species. Members of this family have powerful electric organs and are commonly called electric rays. Electric Rays,Torpedinidae,Rays, Electric
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016716 PC12 Cells A CELL LINE derived from a PHEOCHROMOCYTOMA of the rat ADRENAL MEDULLA. PC12 cells stop dividing and undergo terminal differentiation when treated with NERVE GROWTH FACTOR, making the line a useful model system for NERVE CELL differentiation. Pheochromocytoma Cell Line,Cell Line, Pheochromocytoma,Cell Lines, Pheochromocytoma,PC12 Cell,Pheochromocytoma Cell Lines
D018733 Nicotinic Antagonists Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. Antagonists, Nicotinic

Related Publications

J W Daly, and Y Nishizawa, and W L Padgett, and T Tokuyama, and P J McCloskey, and L Waykole, and A G Schultz, and R S Aronstam
The nicotinic acetylcholine receptor from Torpedo electroplax.
January 1979, Progress in brain research,
J W Daly, and Y Nishizawa, and W L Padgett, and T Tokuyama, and P J McCloskey, and L Waykole, and A G Schultz, and R S Aronstam
Interaction of gephyrotoxin and indolizidine alkaloids with the nicotinic acetylcholine receptor-ion channel complex of Torpedo electroplax.
August 1986, Neurochemical research,
J W Daly, and Y Nishizawa, and W L Padgett, and T Tokuyama, and P J McCloskey, and L Waykole, and A G Schultz, and R S Aronstam
Monoclonal rat anti-Torpedo electroplax nicotinic acetylcholine receptor antibodies: immunochemical characterization.
November 1984, Journal of immunological methods,
J W Daly, and Y Nishizawa, and W L Padgett, and T Tokuyama, and P J McCloskey, and L Waykole, and A G Schultz, and R S Aronstam
Allosteric modulation of Torpedo nicotinic acetylcholine receptor ion channel activity by noncompetitive agonists.
January 1997, Journal of receptor and signal transduction research,
J W Daly, and Y Nishizawa, and W L Padgett, and T Tokuyama, and P J McCloskey, and L Waykole, and A G Schultz, and R S Aronstam
Acetylcholine receptor oligomers from electroplax of Torpedo species.
June 1976, Biochemistry,
J W Daly, and Y Nishizawa, and W L Padgett, and T Tokuyama, and P J McCloskey, and L Waykole, and A G Schultz, and R S Aronstam
Ultraviolet light-induced labeling by noncompetitive blockers of the acetylcholine receptor from Torpedo marmorata.
June 1981, Proceedings of the National Academy of Sciences of the United States of America,
J W Daly, and Y Nishizawa, and W L Padgett, and T Tokuyama, and P J McCloskey, and L Waykole, and A G Schultz, and R S Aronstam
Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata.
June 1983, Biochemistry,
J W Daly, and Y Nishizawa, and W L Padgett, and T Tokuyama, and P J McCloskey, and L Waykole, and A G Schultz, and R S Aronstam
Properties of lubrol-solubilized acetylcholine receptor from Torpedo electroplax.
May 1972, Archives of biochemistry and biophysics,
J W Daly, and Y Nishizawa, and W L Padgett, and T Tokuyama, and P J McCloskey, and L Waykole, and A G Schultz, and R S Aronstam
Two binding sites in acetylcholine receptor from Torpedo marmorata electroplax.
December 1974, Archives of biochemistry and biophysics,
J W Daly, and Y Nishizawa, and W L Padgett, and T Tokuyama, and P J McCloskey, and L Waykole, and A G Schultz, and R S Aronstam
Photoaffinity labeling the torpedo nicotinic acetylcholine receptor with [(3)H]tetracaine, a nondesensitizing noncompetitive antagonist.
August 1999, Molecular pharmacology,
Copied contents to your clipboard!